 |
0 Diseases |  |
1 Trial |
|
1 Trial |  |
9 News |  |
- | huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
Trial completion date, Trial primary completion date: Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma (clinicaltrials.gov) - Jun 26, 2018
P1/2, N=20, Active, not recruiting, Sponsor: Translational Biosciences
Trial completion date: Oct 2018 --> Oct 2020 | Trial primary completion date: Apr 2018 --> Apr 2020
- huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
Trial primary completion date: Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma (clinicaltrials.gov) - Apr 28, 2017
P1/2, N=20, Active, not recruiting, Sponsor: Translational Biosciences
Trial completion date: Oct 2018 --> Oct 2020 | Trial primary completion date: Apr 2018 --> Apr 2020 Trial primary completion date: Feb 2017 --> Apr 2018
- huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
Enrollment change, Trial withdrawal, Trial primary completion date: Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis (clinicaltrials.gov) - Apr 28, 2017
P1/2, N=0, Withdrawn, Sponsor: Translational Biosciences
Trial primary completion date: Feb 2017 --> Apr 2018 N=40 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> Dec 2018
- huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
Trial primary completion date: Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma (clinicaltrials.gov) - Oct 19, 2016
P1/2, N=20, Active, not recruiting, Sponsor: Translational Biosciences
N=40 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Dec 2016 --> Dec 2018 Trial primary completion date: Jun 2016 --> Feb 2017
- | huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
Enrollment closed: Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma (clinicaltrials.gov) - Feb 5, 2016
P1/2, N=20, Active, not recruiting, Sponsor: Translational Biosciences
Trial primary completion date: Jun 2016 --> Feb 2017 Recruiting --> Active, not recruiting
- | huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
Enrollment closed, Trial primary completion date: Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis (clinicaltrials.gov) - Feb 5, 2016
P1/2, N=40, Active, not recruiting, Sponsor: Translational Biosciences
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
- huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
Trial primary completion date: Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma (clinicaltrials.gov) - Sep 24, 2015
P1/2, N=20, Recruiting, Sponsor: Translational Biosciences
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- | huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
New P1/2 trial: Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma (clinicaltrials.gov) - Jul 17, 2014
P1/2, N=20, Recruiting, Sponsor: Translational Biosciences
- | huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama
New P1/2 trial: Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis (clinicaltrials.gov) - Dec 4, 2013
P1/2, N=40, Recruiting, Sponsor: Translational Biosciences